Pharmasset Appoints Patrick T. Higgins as Executive Vice President, Marketing & Sales
storical facts are forward-looking statements that involve risks and uncertainties including without limitation the riskthat our collaboration with Roche will not continue or will not besuccessful the risk that the on-going or anticipated clinical trials forany one or more of our product candidates will not be successful or willnot provide meaningful data and the risk that any one or more
Date:11/26/2007
storical facts are "forward-looking statements"
that involve risks and uncertainties, including without limitation the risk
that our collaboration with Roche will not continue or will not be
successful, the risk that the on-going or anticipated clinical trials for
any one or more of our product candidates will not be successful or will
not provide meaningful data and the risk that any one or more of our
product candidates will not be successfully developed and commercialized.
For a discussion of these risks and uncertainties, any of which could cause
our actual results to differ from those contained in the forward-looking
statements, see the section of our Quarterly Report on Form 10-Q for the
quarter ended June 30, 2007 filed with the Securities and Exchange
Commission entitled "Risk Factors" and discussions of potential risks and
uncertainties in our subsequent filings with the Securities and Exchange
Commission.
'/>"/>SOURCE Pharmasset, Inc. Copyright©2007 PR Newswire. All rights reserved | |
Page: 1 2 3 Related medicine news :1.
Pharmassets Underwriters Release Shares from Lock-Up2.
Pharmasset Presents R7128 14-Day Monotherapy Study Results for the Treatment of Chronic Hepatitis C3.
WorldHeart Appoints David Pellone Chief Financial Officer4.
Novo Nordisk Appoints New Leader of North American Business5.
The American Liver Foundation Appoints Rick Smith, a Twenty-Year Veteran of The MS Society, as Chief Executive Officer6.
Millstone Medical Outsourcing Appoints Operations Manager of New Memphis, TN, Facility7.
China Holdings Appoints Ronald Shon Chairman of Advisory Board to Its Wholly-Owned Subsidiary China Power, Inc.8.
Resonant Medical Appoints New Vice President of Global Sales9.
Response Biomedical appoints S. Wayne Kay Chief Executive Officer10.
Stem Cell Therapy Disappoints Against Rare Kidney Ailment11.
EPI-Q Opens East Coast Office and Appoints Vice President-Business Development